BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2022 7:19:39 AM | Browse: 696 | Download: 1516
 |
Received |
|
2022-01-12 06:24 |
|
Peer-Review Started |
|
2022-01-12 06:26 |
|
First Decision by Editorial Office Director |
|
2022-02-08 10:44 |
|
Return for Revision |
|
2022-02-08 10:44 |
|
Revised |
|
2022-03-05 14:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-06-01 02:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-06-03 21:42 |
|
Articles in Press |
|
2022-06-03 21:42 |
|
Edit the Manuscript by Language Editor |
|
2022-05-25 17:49 |
|
Typeset the Manuscript |
|
2022-06-13 09:04 |
|
Publish the Manuscript Online |
|
2022-06-24 07:19 |
| ISSN |
2220-6132 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Current progress and emerging technologies for generating extra-pancreatic functional insulin producing cells
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Md Aejaz Habeeb, Sandeep Kumar Vishwakarma, Safwaan Habeeb and Aleem Ahmed Khan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Md Aejaz Habeeb, MBBS, MD, PhD, Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh, DMRL X Road, Hyderabad 500058, Telangana, India. aejazhabeeb@hotmail.com |
| Key Words |
Diabetes mellitus; Cell-based therapy; Insulin producing cells; Extra-pancreatic sources; Biomaterials; Tissue engineering |
| Core Tip |
The currently accepted available treatment strategies for uncontrolled diabetes mellitus (DM) are pancreas and islet transplantation. However, these strategies are limited due to unavailability of quality pancreas/islet donors, life-long need of immunosuppressant and associated complications. Exogenous insulin administration is one of the clinically established options for the patients with type 1 DM. Liver could be an appropriate extra-pancreatic source to isolate produce number of insulin producing cells due to similar embryonic developmental origin. The furthermost need to develop more effective diabetes cell-based therapies lies in the advancements of robust sensitive micro and nanodevices for exogenous insulin-delivery. |
| Publish Date |
2022-06-24 07:19 |
| Citation |
Habeeb MA, Vishwakarma SK, Habeeb S, Khan AA. Current progress and emerging technologies for generating extrapancreatic functional insulin-producing cells. World J Transl Med 2022; 10(1): 1-13 |
| URL |
https://www.wjgnet.com/2220-3230/full/v10/i1/1.htm |
| DOI |
https://dx.doi.org/10.5528/wjtm.v10.i1.1 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
